Peak Cardiac Power Measured Noninvasively With a Bioreactance Technique Is a Predictor of Adverse Outcomes in Patients With Advanced Heart Failure

Congestive Heart Failure

Volumn 16, Issue 6, 2010, Pages 254-258

  Rosenblum, Hannah ^a,b   Helmke, Stephen ^a   Williams, Paula ^a   Teruya, Sergio ^a   Jones, Margaret ^a   Burkhoff, Daniel ^a   Mancini, Donna ^a   Maurer, Mathew S ^a  

^a NewYork Presbyterian Hospital   (United States)

^b Och Spine at New York Presbyterian Hospitals   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; ARTERIAL PRESSURE; ARTICLE; BICYCLE ERGOMETER; CARDIOPULMONARY EXERCISE TEST; CONTROLLED STUDY; DEATH; FEMALE; FOLLOW UP; HEART ASSIST DEVICE; HEART EJECTION FRACTION; HEART FAILURE; HEART GRAFT; HEART OUTPUT; HIGH RISK PATIENT; HUMAN; INFORMATION; MAJOR CLINICAL STUDY; MALE; OUTCOME ASSESSMENT; OXYGEN CONSUMPTION; PREDICTION; PRIORITY JOURNAL; PROGNOSIS;

BICYCLING; CARDIAC OUTPUT, LOW; DISEASE PROGRESSION; EXERCISE TEST; EXERCISE TOLERANCE; FEMALE; HEALTH STATUS INDICATORS; HEART FAILURE; HEMODYNAMICS; HUMAN ENGINEERING; HUMANS; KAPLAN-MEIER ESTIMATE; MALE; MIDDLE AGED; NEW YORK; OXYGEN CONSUMPTION; PROGNOSIS; PROSPECTIVE STUDIES; RISK ASSESSMENT; ROC CURVE; STATISTICS AS TOPIC; STROKE VOLUME; VENTRICULAR FUNCTION, LEFT;

EID: 78649488161     PISSN: 15275299     EISSN: 17517133     Source Type: Journal    
DOI: 10.1111/j.1751-7133.2010.00187.x     Document Type: Article

References (23)

1. Mancini D, Katz S, Donchez L, Aaronson K. Coupling of hemodynamic measurements with oxygen consumption during exercise does not improve risk stratification in patients with heart failure. Circulation. 1996;94:2492-2496.
2. Wilson JR, Rayos G, Yeoh TK, Gothard P. Dissociation between peak exercise oxygen consumption and hemodynamic dysfunction in potential heart transplant candidates. J Am Coll Cardiol. 1995;26:429-435.
3. Tan LB. Cardiac pumping capability and prognosis in heart failure. Lancet. 1986;2:1360-1363.
4. Griffin BP, Shah PK, Ferguson J, Rubin SA. Incremental prognostic value of exercise hemodynamic variables in chronic congestive heart failure secondary to coronary artery disease or to dilated cardiomyopathy. Am J Cardiol. 1991;67:848-853.
5. Roul G, Moulichon ME, Bareiss P, et al. Prognostic factors of chronic heart failure in NYHA class II or III: value of invasive exercise haemodynamic data. Eur Heart J. 1995;16:1387-1398.
6. Chomsky DB, Lang CC, Rayos GH, et al. Hemodynamic exercise testing. A valuable tool in the selection of cardiac transplantation candidates. Circulation. 1996;94:3176-3183.
7. Metra M, Faggiano P, D'Aloia A, et al. Use of cardiopulmonary exercise testing with hemodynamic monitoring in the prognostic assessment of ambulatory patients with chronic heart failure. J Am Coll Cardiol. 1999;33:943-950.
8. Williams SG, Cooke GA, Wright DJ, et al. Peak exercise cardiac power output; a direct indicator of cardiac function strongly predictive of prognosis in chronic heart failure. Eur Heart J. 2001;22:1496-1503.
9. Lang C, Karlin P, Haythe J, et al. Peak cardiac power, measured noninvasively, is a powerful predictor of outcome in chronic heart failure. Circ Heart Fail. 2009;2:33-38.
10. Keren H, Burkhoff D, Squara P. Evaluation of a noninvasive continuous cardiac output monitoring system based on thoracic bioreactance. Am J Physiol Heart Circ Physiol. 2007;293:H583-H589.
11. Myers J, Gujja P, Neelagaru S, Burkhoff D. Cardiac output and cardiopulmonary responses to exercise in heart failure: application of a new bio-reactance device. J Card Fail. 2007;13:629-636.
12. Myers J, Gujja P, Neelagaru S, et al. End-tidal CO2 pressure and cardiac performance during exercise in heart failure. Med Sci Sports Exerc. 2009;41:19-25.
13. Raval NY, Squara P, Cleman M, et al. Multicenter evaluation of noninvasive cardiac output measurement by bioreactance technique. J Clin Monit Comput. 2008;22:113-119.
14. Maurer M, Burkhoff D, Maybaum S, et al. A multicenter study of noninvasive cardiac output during symptom limited exercise. J Card Fail. 2009;15(8):689-699.
15. Mancini DM, Eisen H, Kussmaul W, et al. Value of peak exercise oxygen consumption for optimal timing of cardiac transplantation in ambulatory patients with heart failure. Circulation. 1991;83:778-786.
16. Lang CC, Agostoni P, Mancini DM. Prognostic significance and measurement of exercise-derived hemodynamic variables in patients with heart failure. J Card Fail. 2007;13:672-679.
17. Kitzman DW, Higginbotham MB, Cobb FR, et al. Exercise intolerance in patients with heart failure and preserved left ventricular systolic function: failure of the Frank-Starling mechanism. J Am Coll Cardiol. 1991;17:1065-1072.
18. Goda A, Lang CC, Williams P, et al. Usefulness of non-invasive measurement of cardiac output during sub-maximal exercise to predict outcome in patients with chronic heart failure. Am J Cardiol. 2009;104: 1556-1560.
19. Connors AF Jr, Speroff T, Dawson NV, et al. The effectiveness of right heart catheterization in the initial care of critically ill patients. SUPPORT Investigators. JAMA. 1996;276:889-897.
20. Binanay C, Califf RM, Hasselblad V, et al. Evaluation study of congestive heart failure and pulmonary artery catheterization effectiveness: the ESCAPE trial. JAMA. 2005;294:1625-1633.
21. Marque S, Cariou A, Chiche JD, Squara P. Comparison between Flotrac-Vigileo and Bioreactance, a totally noninvasive method for cardiac output monitoring. Crit Care. 2009;13:R73.
22. Squara P, Cecconi M, Rhodes A, et al. Tracking changes in cardiac output: methodological considerations for the validation of monitoring devices. Intensive Care Med. 2009;35:1801-1808.
23. Squara P, Denjean D, Estagnasie P, et al. Noninvasive cardiac output monitoring (NICOM): a clinical validation. Intensive Care Med. 2007;33:1191-1194.